{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:36:20Z","timestamp":1772310980604,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Natural Science Funds for Young Scholars","award":["81200211"],"award-info":[{"award-number":["81200211"]}]},{"name":"Key R&D program in Shandong Province","award":["2015GGA01027"],"award-info":[{"award-number":["2015GGA01027"]}]},{"name":"Shandong Young Scientists Award Fund","award":["2012BSA01018"],"award-info":[{"award-number":["2012BSA01018"]}]},{"name":"Scientific and Technology Development Program of Jinan","award":["20120144"],"award-info":[{"award-number":["20120144"]}]},{"name":"Scientific and Technology Development Program of Jinan","award":["201704118"],"award-info":[{"award-number":["201704118"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biocel.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T12:54:54Z","timestamp":1539608094000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4H\u03b11 in ApoE\u2212\/\u2212 mice"],"prefix":"10.1016","volume":"105","author":[{"given":"Xiao-Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biocel.2018.10.002_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-153-6-201009210-00272","article-title":"The vulnerable atherosclerotic plaque: scope of the literature","volume":"153","author":"Alsheikh-Ali","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.biocel.2018.10.002_bib0010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.drudis.2017.03.001","article-title":"Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins","volume":"22","author":"Banfi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biocel.2018.10.002_bib0015","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1038\/ki.2008.514","article-title":"Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST: New strategies to prevent cardiovascular risk in chronic kidney disease","volume":"74","author":"Blanco-Colio","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.biocel.2018.10.002_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.pmbts.2017.01.004","article-title":"Evidence for the involvement of matrix-degrading metalloproteinases (MMPs) in atherosclerosis","volume":"147","author":"Brown","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"9","key":"10.1016\/j.biocel.2018.10.002_bib0025","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00125-008-1060-6","article-title":"The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation","volume":"51","author":"Calkin","year":"2008","journal-title":"Diabetologia"},{"issue":"16","key":"10.1016\/j.biocel.2018.10.002_bib0030","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1074\/jbc.M511237200","article-title":"Human prolyl-4-hydroxylase \u03b1 (I) transcription is mediated by upstream stimulatory factors","volume":"281","author":"Chen","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.biocel.2018.10.002_bib0035","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/CIRCULATIONAHA.105.590018","article-title":"Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress","volume":"113","author":"Cheng","year":"2006","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.biocel.2018.10.002_bib0040","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/ehr068","article-title":"Imaging of atherosclerosis: magnetic resonance imaging","volume":"32","author":"Corti","year":"2011","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biocel.2018.10.002_bib0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.14.1.591","article-title":"Immune regulation by CD40 and its ligand GP39","volume":"14","author":"Foy","year":"1996","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biocel.2018.10.002_bib0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biocel.2018.10.002_bib0055","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.amjcard.2004.04.037","article-title":"Effect of atorvastatin on the expression of CD40 ligand and P-selectin on platelets in patients with hypercholesterolemia","volume":"94","author":"Hwang","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.biocel.2018.10.002_bib0060","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.2515","article-title":"Arterial thrombosis\u2014insidious, unpredictable and deadly","volume":"17","author":"Jackson","year":"2011","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biocel.2018.10.002_bib0065","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.ATV.0000261873.86623.e1","article-title":"Assessment of unstable atherosclerosis in mice","volume":"27","author":"Jackson","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.biocel.2018.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.103.8.1164","article-title":"Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E\u2013deficient and low-density lipoprotein receptor\u2013deficient mice","volume":"103","author":"Jan","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biocel.2018.10.002_bib0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.CIR.0000136588.62638.5E","article-title":"Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study","volume":"110","author":"Kinlay","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biocel.2018.10.002_bib0080","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1172\/JCI109938","article-title":"Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated wit h mevinolin, a competitive inhibitor of the reductase","volume":"66","author":"Kita","year":"1980","journal-title":"J. Clin. Invest."},{"issue":"02","key":"10.1016\/j.biocel.2018.10.002_bib0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1160\/TH09-01-0029","article-title":"The multi-functionality of CD40L and its receptor CD40 in atherosclerosis","volume":"101","author":"Lievens","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.biocel.2018.10.002_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1050-1738(01)00142-6","article-title":"CD40-CD40L interactions in atherosclerosis","volume":"12","author":"Lutgens","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.biocel.2018.10.002_bib0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcm.2007.02.004","article-title":"CD40 and its ligand in atherosclerosis","volume":"17","author":"Lutgens","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.biocel.2018.10.002_bib0100","first-page":"677","article-title":"Biomarkers in cardiovascular medicine","volume":"62","author":"Mart\u00edn-Ventura","year":"2009","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Ed.)"},{"issue":"5","key":"10.1016\/j.biocel.2018.10.002_bib0105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.phrs.2007.02.001","article-title":"Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice","volume":"55","author":"Monetti","year":"2007","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biocel.2018.10.002_bib0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0945-053X(03)00006-4","article-title":"Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis","volume":"22","author":"Myllyharju","year":"2003","journal-title":"Matrix Biol."},{"issue":"12","key":"10.1016\/j.biocel.2018.10.002_bib0115","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.108.173898","article-title":"Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability","volume":"28","author":"Newby","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.biocel.2018.10.002_bib0120","doi-asserted-by":"crossref","first-page":"H1598","DOI":"10.1152\/ajpheart.01202.2008","article-title":"Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice","volume":"296","author":"Ni","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.biocel.2018.10.002_bib0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.thromres.2012.12.006","article-title":"Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects","volume":"131","author":"Patterson","year":"2013","journal-title":"Thromb. Res."},{"issue":"05","key":"10.1016\/j.biocel.2018.10.002_bib0130","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1160\/TH10-09-0589","article-title":"Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo","volume":"105","author":"Quillard","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.biocel.2018.10.002_bib0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","article-title":"CD40\u2013CD40 ligand interactions in oxidative stress, inflammation and vascular disease","volume":"14","author":"Rizvi","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"01","key":"10.1016\/j.biocel.2018.10.002_bib0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1160\/TH04-07-0415","article-title":"Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury","volume":"93","author":"Sch\u00e4fer","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.biocel.2018.10.002_bib0145","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/hh2401.101272","article-title":"CD40 signaling and plaque instability","volume":"89","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biocel.2018.10.002_bib0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0735-1097(02)02718-3","article-title":"Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy","volume":"41","author":"Semb","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.biocel.2018.10.002_bib0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10557-008-6147-2","article-title":"Inflammation and plaque vulnerability","volume":"23","author":"Shah","year":"2009","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"5","key":"10.1016\/j.biocel.2018.10.002_bib0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MOL.0000000000000112","article-title":"Collagen and related extracellular matrix proteins in atherosclerotic plaque development","volume":"25","author":"Shami","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"10.1016\/j.biocel.2018.10.002_bib0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0021-9150(00)00708-5","article-title":"Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins","volume":"157","author":"Shiomi","year":"2001","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.biocel.2018.10.002_bib0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.ATV.21.1.115","article-title":"Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering","volume":"21","author":"Sparrow","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.biocel.2018.10.002_bib0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tcm.2010.12.004","article-title":"From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand","volume":"20","author":"Tousoulis","year":"2010","journal-title":"Trends Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.biocel.2018.10.002_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153919","article-title":"Rosuvastatin attenuates CD40L-induced downregulation of extracellular matrix production in human aortic smooth muscle cells via TRAF6-JNK-NF-\u03baB pathway","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biocel.2018.10.002_bib0185","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biocel.2018.10.002_bib0190","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1582-4934.2010.01028.x","article-title":"Combinatorial interference of toll\u2010like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E\u2010knockout mice","volume":"15","author":"Yang","year":"2011","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.biocel.2018.10.002_bib0195","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/ATVBAHA.107.144881","article-title":"TNF-\u03b1 suppresses prolyl-4-hydroxylase \u03b11 expression via the ASK1\u2013JNK\u2013NonO pathway","volume":"27","author":"Zhang","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biocel.2018.10.002_bib0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2013.09.010","article-title":"Simvastatin increases Prolyl-4-Hydroxylase \u03b11 expression in atherosclerotic plaque and ox-LDL-stimulated human aortic smooth muscle cells via p38 MAPK and ERK1\/2 signaling","volume":"65","author":"Zhang","year":"2013","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272518302176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272518302176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:13:13Z","timestamp":1761203593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272518302176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":40,"alternative-id":["S1357272518302176"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2018.10.002","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4H\u03b11 in ApoE\u2212\/\u2212 mice","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}